Evidence map›Paper›PMID 33620149›Full record

ArticleMolecular genetics & genomic medicine2021

Clinical manifestation and phenotypic analysis of novel gene mutation in 28 Chinese children with hereditary spherocytosis.

Fei Xie, Lei Lei, Bin Cai, Lu Gan, Yu Gao, Xiaoying Liu, Lin Zhou, Jinjin Jiang

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Identification of a novelFrontiers in genetics · 2024
    Article
  6. Article
  7. Article
  8. Clinical and genetic diagnosis for 26 paitents with hereditary spherocytosis.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fei XieDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.ORCID 0000-0001-6718-8229
Lei LeiDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.
Bin CaiDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.
Lu GanDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.
Yu GaoDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.
Xiaoying LiuDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.
Lin ZhouDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.
Jinjin JiangDepartment of Pediatrics, Changhai Hospital, Naval Military Medical University, Shanghai, China.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeObjective to summarize the clinical features and laboratory findings of 28 Chinese children with hereditary spherocytosis (HS), and analyze these mutations.

methodCollected and analyzed the clinical data of all children and their parents, and completed the relevant laboratory examinations of all children. Analyzed the sequence of related genes by second-generation sequencing technology, and verified the suspected mutations by Sanger sequencing method. Analyzed all biological information using the Single Nucleotide Polymorphism database, the 1000 Human Genome Project, and the Exosome Aggregation Consortium.

resultNew mutations were detected in the HS coding region of 28 children. Among them, there were 13 cases (46.4%) with ANK1 mutation, 10 cases (35.7%) with SPTB mutation, three cases (10.7%) with SLC4A1 mutation, and two cases (7.2%) with SPTA1 mutation. All mutations cause amino acid changes in the coding gene, as well as subsequent changes in protein structure or loss of function.

conclusionAll the newly discovered gene coding region mutation sites detected are the suspected pathogenic causes of the 28 Chinese children. At the same time, the second-generation gene sequencing technology is an effective means to diagnose HS. Different mutation types and different mutation regions have no significant correlation with the severity of anemia. The novel gene mutation sites in 28 children studied in this paper have not yet been included in the human genome database, dbSNP (v138), or ExAC database. The new gene mutations found in HS children can provide a theoretical basis for further exploring the genetic causes of HS in Chinese children.

Indexed as

Loss of Function MutationPhenotypeAnion Exchange Protein 1, ErythrocyteAnkyrinsChildChild, PreschoolFemaleHumansInfantMaleSpectrinSpherocytosis, HereditaryAnion Exchange Protein 1, ErythrocyteANK1 protein, humanAnkyrinsSLC4A1 protein, humanSpectrinSPTB protein, humanANK1childrengene mutationhereditary spherocytosisSLC41SPTA1SPTB

Identifiers

PMID33620149
PMCPMC8123760
OpenAlexW3131306920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.